Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Thermotherapy of Buruli Ulcer

In: Buruli Ulcer: Mycobacterium Ulcerans Disease [Internet]. Cham (CH): Springer; 2019.
.
Affiliations
Free Books & Documents
Review

Thermotherapy of Buruli Ulcer

Thomas Junghanss.
Free Books & Documents

Excerpt

The temperature sensitivity of M. ulcerans has long been recognized. Meyers et al. in the 1970ies successfully treated patients with local heat application. Based on this success, WHO guidelines listed the application of heat as a treatment option for BU in 2000. However, the heat application devices initially employed were impractical. The phase change material (PCM) sodium acetate trihydrate, offers an ideal technical solution. Both, a proof-of-principle and a phase II trial showed that thermotherapy with rechargeable heat packs filled with sodium acetate is well tolerated and effective. Heat packs can be applied in early, undifferentiated stages of disease without causing harm and with the benefit of preventing advancement into severe complicated disease. Thermotherapy is highly effective, easy to apply, cheap, well tolerated, free of relevant adverse effects and has nonspecific positive effects on wound healing.

PubMed Disclaimer

Sections

References

    1. Junghanss T, Johnson RC, Pluschke G (2014) Mycobacterium ulcerans disease. In: Farrar J et al (eds) Manson’s tropical diaseses. Elsevier Saunders, Philadelphia, pp 519–531
    1. WHO, Asiedu K (2004) Provisional guidance on the role of specific antiobiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer), vol 39. WHO/Department of Communicable Disease Prevention, Control and Eradication, Geneva
    1. WHO, Asiedu K (2012) Treatment of Mycobacterium ulcerans disease (Buruli Ulcer). WHO/Department of Control of Neglected Tropical Diseases, Geneva, p 73
    1. Nienhuis WA et al (2010) Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 375(9715):664–672 - PubMed
    1. Klis S et al (2014) Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial. PLoS Negl Trop Dis 8(3):e2739 - PMC - PubMed

LinkOut - more resources